Bicycle Therapeutics PLC (BCYC)

NASDAQ: BCYC · IEX Real-Time Price · USD
17.49
+0.71 (4.23%)
At close: Jul 1, 2022 4:00 PM
17.25
-0.24 (-1.37%)
After-hours: Jul 1, 2022 5:34 PM EDT

Stock Price Forecast

According to 19 stock analysts, the average 12-month stock price forecast for BCYC stock is $61.44, which predicts an increase of 251.29%. The lowest target is $33.33 and the highest is $84. On average, analysts rate BCYC stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $33.33 $61.44 $66.3 $84
Change +90.57% +251.29% +279.07% +380.27%

Analyst Ratings

The average analyst rating for BCYC stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 666666
Buy 101111111010
Hold 112233
Sell 000000
Strong Sell 000000
Total 171819191919

Financial Forecast

Revenue This Year
16.58M
Increased by 41.78%
Revenue Next Year
18.17M
Increased by 9.54%
EPS This Year
-3.55
EPS Next Year
-4.07
Year 2017201820192020202120222023202420252026
Revenue
2.06M7.14M13.80M10.39M11.70M16.58M18.17M19.97M21.48M23.57M
Revenue Growth
-
246.41%
93.40%
-24.72%
12.58%
41.78%
9.54%
9.92%
7.58%
9.73%
EPS
-48.81-49.78-2.77-2.66-2.67-3.55-4.07-4.89-3.96-3.27
EPS Growth
----------
No. Analysts -----15151399

Revenue Forecast

Revenue 20222023202420252026
High 21.0M 26.3M 40.1M 22.6M 24.5M
Avg 16.6M 18.2M 20.0M 21.5M 23.6M
Low 13.7M 14.4M n/a 20.8M 22.9M

Revenue Growth

Revenue Growth 20222023202420252026
High
54.9%
58.3%
120.8%
13.0%
14.1%
Avg
22.3%
9.5%
9.9%
7.6%
9.7%
Low
1.2%
-13.1%
-
4.3%
6.4%

EPS Forecast

EPS 20222023202420252026
High -2.91 -3.10 -3.78 -4.16 -3.40
Avg -3.55 -4.07 -4.89 -3.96 -3.27
Low -5.04 -6.07 -6.44 -3.84 -3.17

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -